Oculus

Oculus Innovative Sciences Reports Second Quarter FY 2010: 60% Reduction in Operating Expenses and 16% Increase in Product Revenue 37% in Local Currency.(Financial report)
Biotech Week; 11/18/2009; 1379 words; Oculus Innovative Sciences, Inc. (NASDAQ:OCLS...year 2010, ended September 30, 2009. Oculus reported total revenue of $1.7 million...dollar revenue growth was 34% (see also Oculus Innovative Sciences, Inc.). "In our...

News and FDA Updates for Oculus (NASDAQ:OCLS), Orthovita (NASDAQ:VITA), Ore Pharmaceutical (NASDAQ:ORXE).
M2 Presswire; 11/16/2009; 997 words; ...16 November 2009-BiomedReports: News and FDA Updates for Oculus (NASDAQ:OCLS), Orthovita (NASDAQ:VITA), Ore Pharmaceutical...developments can be found on BioMedReports.Com On 13/11/09, Oculus Innovative Sciences, Inc. (NASDAQ:OCLS), a biopharmaceutical...

USPTO Issues Trademark PARK 1 to Oculus Optikgeraete for Ophthalmologic Apparatus, Instruments for Scientific Use
US Fed News Service, Including US State News; 11/14/2009; 503 words; ALEXANDRIA, Va., Nov. 14 -- Oculus Optikgeraete GmbH, Wetzlar-Dutenhofen, Germany, has been issued the trademark PARK 1 (Reg. No 3709312) by the USPTO. The...

www.Xtremepicks.Com: Xtremepicks Alerts November 13, 2009 : ARAY, ROST, PFSW and OCLS.
M2 Presswire; 11/13/2009; 1655 words; ...Furterer USA, Roots Canada Ltd. and Xerox. Oculus Innovative Sciences, Inc. (NASDAQ...In a press release out on November 13, Oculus Innovative Sciences' Development Partner...PETALUMA, Calif., Nov 13, 2009 -- Oculus Innovative Sciences, Inc. (NASDAQ...

Study data from Federal University update understanding of dengue fever.(Report)
Biotech Week; 11/11/2009; 926 words; ...thickness (mu m) and reflectivity. All patients presented low visual acuity and scotomata with or without changes in the oculus fundus. tPERG from two patients showed decreased amplitude or absence of the main components; it was not possible to record...